Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Receivables (2017)

Historic Receivables for KalVista Pharmaceuticals (KALV) over the last 1 years, with Q4 2017 value amounting to $7.3 million.

  • KalVista Pharmaceuticals' Receivables changed N/A to $7.3 million in Q4 2017 from the same period last year, while for Oct 2017 it was $7.3 million, marking a year-over-year change of. This contributed to the annual value of $7.6 million for FY2017, which is N/A changed from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Receivables of $7.3 million as of Q4 2017.
  • In the past 5 years, KalVista Pharmaceuticals' Receivables ranged from a high of $7.6 million in Q2 2017 and a low of $7.3 million during Q4 2017